The applicant, an American pharmaceutical company, sought to enforce amended letters rogatory issued by a United States District Court to compel testimony and documentary evidence from the respondent, a federal Crown corporation, for use in foreign litigation.
The respondent opposed the application, arguing that it enjoyed Crown immunity.
The court held that the presumption of Crown immunity under s. 17 of the federal Interpretation Act prevented the enforcement of letters rogatory against a Crown agent, as the provincial Evidence Act does not bind the federal Crown.
Furthermore, the court found that the applicant failed to satisfy the legal standard for enforcing letters rogatory, as the evidence sought was not necessary for trial and had already been obtained through an Access to Information Act request.
The application was dismissed.